Therefore in accordance with Article 21(3) of Regulation (EC) No 1107/2009 in conjunction with Article 6 thereof, it is necessary and appropriate to restrict the approval of cyflumetofen.
Recital 10, Regulation (EU) 2019/716
In forcesince 30 Apr 2019